Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3) – Scholarship and Grants Opportunities

    0
    365
    Funding Opportunity ID: 310037
    Opportunity Number: RFA-CA-19-012
    Opportunity Title: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)
    Opportunity Category: Discretionary
    Opportunity Category Explanation:
    Funding Instrument Type: Cooperative Agreement
    Category of Funding Activity: Education
    Environment
    Health
    Category Explanation:
    CFDA Number(s): 93.113
    93.121
    93.353
    93.393
    93.853
    Eligible Applicants: State governments
    County governments
    City or township governments
    Special district governments
    Independent school districts
    Public and State controlled institutions of higher education
    Native American tribal governments (Federally recognized)
    Public housing authorities/Indian housing authorities
    Native American tribal organizations (other than Federally recognized tribal governments)
    Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
    Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
    Private institutions of higher education
    For profit organizations other than small businesses
    Small businesses
    Others (see text field entitled “Additional Information on Eligibility” for clarification)
    Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
    Agency Code: HHS-NIH11
    Agency Name: Department of Health and Human Services
    National Institutes of Health
    Posted Date: Oct 31, 2018
    Close Date: Feb 11, 2019
    Award Ceiling: $500,000
    Award Floor: $0
    Estimated Total Program Funding: $2,000,000
    Expected Number of Awards:
    Description: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to support UG3/UH3 phased award Projects as part of the expanded Immuno-Oncology Translational Network (IOTN). The IOTN will form an integrated network of multi-disciplinary, collaborative teams with the overarching goals of accelerating translational research of innate and adaptive immune mechanisms that contribute to tumor initiation and progression and evaluating new or improved immunopreventive and immunotherapeutic strategies (including combinations with standard or other therapies). Studies should be largely pre-clinical involving clinically-relevant models and endpoints, and have the potential for rapid translation into early-phase clinical applications. Applicants responding to this FOA must apply for both the UG3 and UH3 phases together in a single application. Exploratory studies aimed at immune target identification and validation will be supported under UG3. Achievement of the UH2 milestones will be necessary for transition to the UH3 Implementation Phase. UH3 phase may be awarded after administrative review of the UH2 milestones. Provided these milestones are achieved, UH3 phase may continue with development and preclinical testing of specific interventions.
    Version: 1

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here